Gastrointestinal Cancer

SS 30 - GI 5- Esophagogastric Cancers

Moderator(s)

• JO

  Jeffrey Olsen, MD

  University of Colorado
• DA

  Diandra Ayala-Peacock, MD

  Vanderbilt University Medical Center

Presentations:

• 8:00 AM - 8:10 AM

  Regional Lymph-Node Failures after Diagnostic Endoscopic Resection Plus Selective Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma: A Multi-Institutional Phase II Study (JCOG0508)
  Presenter: Keiji Nihei, MD, PhD – Tokyo Metropolitan Cancer and Infectious Diseases Center
  Presentation No : 173
• 8:10 AM - 8:20 AM

  High AXL Expression Predicts Worse Overall Survival and Locoregional Recurrence in Esophageal Cancer
  Presenter: Jacob Witt, MD – University of Wisconsin Hospitals and Clinics
  Presentation No : 174
• 8:20 AM - 8:30 AM

  A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA
  Presenter: Jennifer Wo, MD – Massachusetts General Hospital
  Presentation No : 175
• 8:30 AM - 8:40 AM

  Patterns of Recurrence in the Critics Gastric Cancer Trial: Results from Intention-to-Treat and per-Protocol Analyses
  Presenter: Romy van Amelsfoort, MD – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
  Presentation No : 176
• 8:40 AM - 8:50 AM

  Definitive Radiochemotherapy Versus Neoadjuvant Radiochemotherapy Followed by Surgery in Patients Who Achieved Clinical Complete Response when Induction Treatment Finished for Locally Advanced Esophageal Squamous Cell Carcinoma
  Presenter: Dong Qian, MD – Huanhuxilu Tiyuanbei Hexi District Tianjin China
  Presentation No : 177
• 8:50 AM - 9:00 AM

  Discussant
  Discussant: Terence Sio, MD, MS – Mayo Clinic Scottsdale